Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications evaluation survival curve extrapolation techniques using long term observational cancer
Thirteenth Annual FDA Sentinel Initiative Public Workshop Share on: Monday, November 8, 2021, 10am - Tuesday, November 9, 2021, 2pm Workshop registration Image Bradley Layton, PhD , Senior Research Epidemiologist at RTI-HS, will be participating as a …
RTI Health Solutions SharePoint Online (SPO) Third Party User Agreement RTI Health Solutions (RTI-HS) is willing to provide a SharePoint Online (SPO) site, operated out of the U.S., for sharing documents and non-personal or anonymized data between RTI and …
14th Annual Sentinel Initiative Public Workshop Share on: Tuesday, November 15 - Wednesday, November 16, 2022 Event webpage Bradley Layton, PhD, Director, Epidemiology at RTI Health Solutions is giving a presentation at the 14th Annual Sentinel …
… 2023 ESMO Breast Cancer Annual Congress Share on: Thursday, May 11 - … experts will be presented at the 2023 ESMO Breast Cancer Annual Congress. Real-world clinical outcomes … therapy among patients with HR+/HER2− advanced breast cancer in Europe. Oikonomidou O, Galve-Calvo E, Wockel A, …
… German Cancer Congress (Deutscher Krebskongress) Share on: … Health Solutions experts will be presented at the German Cancer Congress (Deutscher Krebskongress). Health-related … gastroesophageal junction, or esophageal adenocarcinoma cancer (GC/GEJC/EAC): 36-month results of CheckMate 649 …
… San Antonio Breast Cancer Symposium Share on: Tuesday, December 6 - Saturday, … experts will be presented at the 2022 San Antonio Breast Cancer Symposium. Real-world treatment patterns and clinical … after prior PI3K inhibitor therapy for metastatic breast cancer. Goyal RK, Zhang J, Davis KL, Kaufman PA. …
… agents such as aspirin or clopidogrel. In this observational study, RTI Health Solutions collaborated with …
… European Lung Cancer Congress (ELCC) 2024 Share on: Wednesday, March 20 - … Solutions experts will be presented at the European Lung Cancer Congress (ELCC) 2024. Treatment (tx) patterns and … receptor-mutation positive (EGFRm) non-small cell lung cancer (NSCLC) treated with chemoradiotherapy (CRT): interim …
… focuses on products that have been on the market for a long time and are the costliest from a Medicare perspective. … Plasma-derived products Small biotech drugs (2026-2028) Using the guidance on drug selection criteria, manufacturers … considered relevant in determining clinical benefit: Cure, survival, progression-free survival, or improved morbidity …
… may have promising subgroup effects Methods & Applications Using innovative analytical methods based on structural … working with data sources from clinical trials , observational studies , and registries . …